
Company Info
Year Established2025
Contacts
Andrew ParlockCo-Founder & CEO
Company Description
BioTarget DX is building the next generation of liquid biopsy and infectious disease diagnostics—scalable, point-of-care (POC) platforms targeting multi-billion-dollar markets.
